Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2011

Open Access 01-12-2011 | Research

Regulation of Toll-like receptor 1 and -2 in neonatal mice brains after hypoxia-ischemia

Authors: Linnea Stridh, Peter LP Smith, Andrew S Naylor, Xiaoyang Wang, Carina Mallard

Published in: Journal of Neuroinflammation | Issue 1/2011

Login to get access

Abstract

Background

Hypoxic-ischemic (HI) brain injury remains a major problem in newborns, resulting in increased risk of neurological disorders. Neonatal HI triggers a broad inflammatory reaction in the brain, including activation of the innate immune system. Toll-like receptors (TLRs), which are key components of the innate immune system, are believed to play a role in adult cerebral ischemic injury. The expression of TLRs in the neonatal brain and their regulation after HI is unknown.

Methods

Wild type C57BL/6, TLR 1 knockout (KO) and TLR 2 KO mice were subjected to HI at postnatal day 9 and sacrificed 30 min, 6 h, 24 h or 5 days after HI. TLR mRNA expression was determined by RT-qPCR and protein and cell type localisation by immunohistochemistry (IHC). To evaluate brain injury, infarct volume was measured in the injured hemisphere.

Results

mRNA expression was detected for all investigated TLRs (TLR1-9), both in normal and HI exposed brains. After HI, TLR-1 was down-regulated at 30 min and up-regulated at 6 h and 24 h. TLR-2 was up-regulated at 6 h and 24 h, and TLR-7 at 24 h. Both TLR-5 and TLR-8 were down-regulated at 24 h and 30 min respectively. IHC showed an increase of TLR-1 in neurons in the ipsilateral hemisphere after HI. TLR-2 was constitutively expressed in astrocytes and in a population of neurons in the paraventricular nucleus in the hypothalamus. No changes in expression were detected following HI. Following HI, TLR-2 KO mice, but not TLR-1 KO, showed a decreased infarct volume compared to wild type (p = 0.0051).

Conclusions

This study demonstrates that TLRs are regulated after HI in the neonatal brain. TLR-1 protein was up-regulated in injured areas of the brain but TLR-1 KO animals were not protected from HI. In contrast, TLR-2 was constitutively expressed in the brain and TLR-2 deficiency reduced HI injury. These data suggest that TLR-2, but not TLR-1, plays a role in neonatal HI brain injury.
Appendix
Available only for authorised users
Literature
1.
Fatemi A, Wilson MA, Johnston MV: Hypoxic-ischemic encephalopathy in the term infant. Clin Perinatol. 2009, 36: 835-858. 10.1016/j.clp.2009.07.011. viiPubMedCentralCrossRefPubMed
2.
3.
Savman K, Blennow M, Gustafson K, Tarkowski E, Hagberg H: Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res. 1998, 43: 746-751. 10.1203/00006450-199806000-00006.CrossRefPubMed
4.
Hedtjarn M, Mallard C, Hagberg H: Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab. 2004, 24: 1333-1351.CrossRefPubMed
5.
Doverhag C, Hedtjarn M, Poirier F, Mallard C, Hagberg H, Karlsson A, Savman K: Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis. 2010, 38: 36-46. 10.1016/j.nbd.2009.12.024.CrossRefPubMed
6.
Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H: Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci. 2002, 22: 5910-5919.PubMed
7.
Svedin P, Hagberg H, Savman K, Zhu C, Mallard C: Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci. 2007, 27: 1511-1518. 10.1523/JNEUROSCI.4391-06.2007.CrossRefPubMed
8.
Aden U, Favrais G, Plaisant F, Winerdal M, Felderhoff-Mueser U, Lampa J, Lelievre V, Gressens P: Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun. 2010, 24: 747-758. 10.1016/j.bbi.2009.10.010.CrossRefPubMed
9.
Kaisho T, Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006, 117: 979-987. 10.1016/j.jaci.2006.02.023. quiz 988CrossRefPubMed
10.
O'Neill LA, Bowie AG: The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007, 7: 353-364. 10.1038/nri2079.CrossRefPubMed
11.
Uematsu S, Akira S: Toll-like receptors and innate immunity. J Mol Med. 2006, 84: 712-725. 10.1007/s00109-006-0084-y.CrossRefPubMed
12.
Kariko K, Ni H, Capodici J, Lamphier M, Weissman D: mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 2004, 279: 12542-12550.CrossRefPubMed
13.
Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, Nitsch R, Weber JR: A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS. J Neurosci. 2008, 28: 2320-2331. 10.1523/JNEUROSCI.4760-07.2008.CrossRefPubMed
14.
Park JS, Svetkauskaite D, He Q, Kim J-Y, Strassheim D, Ishizaka A, Abraham E: Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein. J Biol Chem. 2004, 279: 7370-7377.CrossRefPubMed
15.
Gao Y, Fang X, Tong Y, Liu Y, Zhang B: TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed Pharmacother. 2008
16.
Cao CX, Yang QW, Lv FL, Cui J, Fu HB, Wang JZ: Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun. 2007, 353: 509-514. 10.1016/j.bbrc.2006.12.057.CrossRefPubMed
17.
Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, Krueger C, Nitsch R, Meisel A, Weber JR: Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol. 2007, 190: 28-33. 10.1016/j.jneuroim.2007.07.023.CrossRefPubMed
18.
Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V, Konig J, Lehrach H, Nietfeld W, Trendelenburg G: TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun. 2007, 359: 574-579. 10.1016/j.bbrc.2007.05.157.CrossRefPubMed
19.
Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I: Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke. Circulation. 2007, 115: 1599-1608. 10.1161/CIRCULATIONAHA.106.603431.CrossRefPubMed
20.
Bsibsi M, Ravid R, Gveric D, van Noort JM: Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002, 61: 1013-1021.CrossRefPubMed
21.
Mishra BB, Mishra PK, Teale JM: Expression and distribution of Toll like receptors in the brain during murine neurocysticercosis. J Neuroimmunol. 2006, 181: 46-56. 10.1016/j.jneuroim.2006.07.019.PubMedCentralCrossRefPubMed
22.
Rice JE, Vannucci RC, Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981, 9: 131-141. 10.1002/ana.410090206.CrossRefPubMed
23.
Blomgren K, Hallin U, Andersson AL, Puka-Sundvall M, Bahr BA, McRae A, Saido TC, Kawashima S, Hagberg H: Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J Biol Chem. 1999, 274: 14046-14052. 10.1074/jbc.274.20.14046.CrossRefPubMed
24.
Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP: TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes. J Immunol. 2005, 175: 4320-4330.CrossRefPubMed
25.
Olson JK, Miller SD: Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs. J Immunol. 2004, 173: 3916-3924.CrossRefPubMed
26.
Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, et al: Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA. 2007, 104: 13798-13803. 10.1073/pnas.0702553104.PubMedCentralCrossRefPubMed
27.
Chakravarty S, Herkenham M: Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci. 2005, 25: 1788-1796. 10.1523/JNEUROSCI.4268-04.2005.CrossRefPubMed
28.
Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG: Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem. 2007, 102: 37-50. 10.1111/j.1471-4159.2007.04524.x.CrossRefPubMed
29.
Cameron JS, Alexopoulou L, Sloane JA, DiBernardo AB, Ma Y, Kosaras B, Flavell R, Strittmatter SM, Volpe J, Sidman R, Vartanian T: Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci. 2007, 27: 13033-13041. 10.1523/JNEUROSCI.4290-06.2007.PubMedCentralCrossRefPubMed
30.
Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lu J, Kosaras B, Sidman RL, Volpe JJ, Vartanian T: Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol. 2006, 175: 209-215. 10.1083/jcb.200606016.PubMedCentralCrossRefPubMed
31.
Mallard C, Wang X, Hagberg H: The role of Toll-like receptors in perinatal brain injury. Clin Perinatol. 2009, 36: 763-772. 10.1016/j.clp.2009.07.009. v-viCrossRefPubMed
32.
Laflamme N, Soucy G, Rivest S: Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J Neurochem. 2001, 79: 648-657.CrossRefPubMed
33.
Hua F, Ma J, Ha T, Kelley JL, Kao RL, Schweitzer JB, Kalbfleisch JH, Williams DL, Li C: Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res. 2009, 1262: 100-108.PubMedCentralCrossRefPubMed
34.
Hoffmann O, Braun JS, Becker D, Halle A, Freyer D, Dagand E, Lehnardt S, Weber JR: TLR2 mediates neuroinflammation and neuronal damage. J Immunol. 2007, 178: 6476-6481.CrossRefPubMed
35.
Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M: Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 2007, 9: 1081-1088. 10.1038/ncb1629.CrossRefPubMed
36.
Du X, Fleiss B, Li H, D'angelo B, Sun Y, Zhu C, Hagberg H, Levy O, Mallard C, Wang X: Systemic stimulation of TLR2 impairs neonatal mouse brain development. PloS one. 2011.
37.
Koedel U, Merbt UM, Schmidt C, Angele B, Popp B, Wagner H, Pfister H-W, Kirschning CJ: Acute Brain Injury Triggers MyD88-Dependent, TLR2/4-Independent Inflammatory Responses. Am J Pathol. 2007, 171: 200-213. 10.2353/ajpath.2007.060821.PubMedCentralCrossRefPubMed
38.
Loum-Ribot E, Lafon P, Chaigniau M, Pape JR, Tramu G, Corio M: Paraventricular nucleus neurons producing neurotensin after lipopolysaccharide treatment project to the median eminence. Brain Res. 2004, 1030: 294-296. 10.1016/j.brainres.2004.09.011.CrossRefPubMed
39.
Paladino N, Leone MJ, Plano SA, Golombek DA: Paying the circadian toll: The circadian response to LPS injection is dependent on the Toll-like receptor 4. J Neuroimmunol. 2010, 225: 62-67. 10.1016/j.jneuroim.2010.04.015.CrossRefPubMed
40.
Yamawaki Y, Kimura H, Hosoi T, Ozawa K: MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2010, 298: R403-410. 10.1152/ajpregu.00395.2009.CrossRefPubMed
Metadata
Title
Regulation of Toll-like receptor 1 and -2 in neonatal mice brains after hypoxia-ischemia
Authors
Linnea Stridh
Peter LP Smith
Andrew S Naylor
Xiaoyang Wang
Carina Mallard
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-8-45

Other articles of this Issue 1/2011

Journal of Neuroinflammation 1/2011 Go to the issue

Research

Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis

Research

CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease

Research

Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines

Research

The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesis

Research

Air pollution & the brain: Subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease

Research

Melittin restores proteasome function in an animal model of ALS